The LSX Nordic Congress speaker faculty represents a selection of the best minds in Nordic life sciences and pan-European investment. 

Renee Aguiar-Lucander

CEO

Calliditas Therapeutics

David Bejker

CEO

Affibody

Magnus Björsne

CEO

AZ BioVentureHub

Carsten Borring

Head of Listings & Capital Markets

Nasdaq Copenhagen

Søren Bregenholt

CEO

Alligator Bioscience

Chris Cadman

Senior Associate

Potter Clarkson

Stephan Christgau

Managing Partner

Eir Ventures

Magnus Corfitzen

CEO

Ascelia Pharma

Joe Coveney

VP Corporate Services

OTC Markets Group

Ian Coyne

Consulting Partner

Coulter Partners

Karsten Dalgaard

Senior Partner

McKinsey & Company

Tim Damgaard Christensen

Managing Partner - Denmark

MedTech Bridge

Don DeBethizy

Director

Argenx

John Drakenberg Renander

CEO

Alex Therapeutics

Anna-Karin Edstedt Bonamy

CEO

Doctrin

Roger Franklin

Partner

Hadean Ventures

Miriam Frieden

VP S&E

Novo Nordisk

Matt Gehl

Partner

Covington

Jonathan Gertler

Managing Director, BioVentures MedTech Funds

CEO, Back Bay Life Science Advisors

Luke Gill

VP Clinical Development Services

TFS HealthScience

Pavel Gongora

Associate Partner

McKinsey & Company

Jan Bart Hak

Head Medical Device Department

ProPharma Group

Marius Halvorsen

Head of Investment Banking

Arctic Securities

Niels Erik Holm

Executive Advisor

Reapplix

Keld Flintholm Jørgensen

EVP & CBO

Lundbeck

Chris Jeffers

Partner

Mintz

Jonas Jendi

Investment Director & Head of Analysis

Industrifonden

Tahera Kan

VP Early Innovation Partnering, Johnson & Johnson Innovation

Johnson & Johnson

Petrina Knowles Gjelstrup

SVP People & Organisation

Novo Holdings & The Novo Nordisk Foundation

Adam Kostyal

SVP

Nasdaq

Marianne Larsson

Director

HealthTech Nordic

Mark Laurenzo

Business Development Manager

Iowa Economic Development Authority

Peter Legind-Hansen

Managing Director

Nasdaq Copenhagen

Søren Lemonius

Managing General Partner

Sunstone Life Science Ventures

Rami Levin

CEO

Saniona

Christine Lind

VP Commercial

NDA Group

Christer Månsson

Business Development Manager

Healthtech Nordic

Anders Martin-Löf

CFO

Oncopeptides

Karen McGurk

Executive Director Transactions

MSD

Jeremy McCrohan

Head of Investor Relations

Norway Healthtech

Inka Mero

Founder & Managing Partner

Voima Ventures

Stine Mølgaard

COO & Co-founder

Radiobotics

Søren Moller

Managing Partner

Novo Seeds

Jenni Nordborg

Head of the Office for Life Sciences

Government Offices Sweden

Jacob Nyberg

Managing Partner

Wildeco

Klementina Österberg

CEO

GU Ventures

Gunilla Oswald

CEO

BioArctic

Jesper Ottergren

Partner

Vinge

Tony Proctor

Partner

Potter Clarkson

Richard Reschen

Associate Director Business Development

MSD

John Rudy

Partner

Mintz

Viktor Siewertz

CFO

IRLAB

André Sode

CEO

Liva Healthcare

Lena Soderstrom

Corporate Chair/Board Member to Life Science Companies

Bobby Soni

CBO

BioInnovation Institute

Benny Sorensen

CEO

Hemab

Nikolaj Sørensen

CEO

Orexo

James Stamatis

Vice President, Head of Business Development and Acquisitions

AbbVie

Eric Teder

Country Manager Sweden

Doktor.se

Ingrid Teigland Akay

Managing Partner

Hadean Ventures

Nathalie ter Wengel

European Lead Worldwide Business Development

Pfizer

Brandon Thompson

Special Counsel

Covington

Tobias Thornblad

CEO

MS&C Nordics

Jonathan Tobin

Investment Director

Brandon Capital Partners

Martin Welschof

CEO

BioInvent